{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:15:21Z","timestamp":1790093721555,"version":"4.0.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.biologicals.2011.05.004","type":"journal-article","created":{"date-parts":[[2011,6,29]],"date-time":"2011-06-29T20:53:14Z","timestamp":1309380794000},"page":"195-204","source":"Crossref","is-referenced-by-count":122,"title":["Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications"],"prefix":"10.1016","volume":"39","author":[{"given":"Michael","family":"Br\u00f6ker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"DeTora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. David","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Rappuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2011.05.004_bib1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.biologicals.2011.05.004_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jama.269.2.221","article-title":"Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era","volume":"269","author":"Adams","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.biologicals.2011.05.004_bib3","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/IAI.70.9.4946-4954.2002","article-title":"Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection","volume":"70","author":"Burrage","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2011.05.004_bib4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/erv.09.48","article-title":"Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs","volume":"8","author":"Trotter","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.biologicals.2011.05.004_bib5","series-title":"Vaccines","first-page":"543","article-title":"Pneumococcal conjugate vaccine and pneumococcal common protein vaccines","author":"Black","year":"2008"},{"key":"10.1016\/j.biologicals.2011.05.004_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2011.04.053","article-title":"Comparative effects of carrier proteins on vaccine-induced immune response","author":"Knuf","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.05.004_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1590\/S0001-37652005000200009","article-title":"Vaccines based on the cell surface carbohydrates of pathogenic bacteria","volume":"77","author":"Jones","year":"2005","journal-title":"Acad Bras Cienc"},{"key":"10.1016\/j.biologicals.2011.05.004_bib8","first-page":"35","article-title":"Physicochemical characterisation of the oligosaccharide component of vaccines","volume":"103","author":"Ravenscroft","year":"2000","journal-title":"Dev Biol"},{"key":"10.1016\/j.biologicals.2011.05.004_bib9","series-title":"Handbook of meningococcal disease: infection biology, vaccination, clinical management","first-page":"343","article-title":"Conjugate vaccines","author":"Ravenscroft","year":"2006"},{"key":"10.1016\/j.biologicals.2011.05.004_bib10","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1016\/j.vaccine.2009.07.036","article-title":"Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages","volume":"27","author":"Br\u00f6ker","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.05.004_bib11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4155\/bio.09.181","article-title":"Bioanalysis of meningococcal vaccines","volume":"2","author":"Ravenscroft","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.biologicals.2011.05.004_bib12","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1073\/pnas.80.22.6853","article-title":"Nucleotide sequence of the structural gene for diphtheria toxin carried by corynebacteriophage beta","volume":"80","author":"Greenfield","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biologicals.2011.05.004_bib13","series-title":"New generation vaccines","first-page":"251","article-title":"New and improved vaccines against diphtheria and tetanus","author":"Rappuoli","year":"1990"},{"key":"10.1016\/j.biologicals.2011.05.004_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/357216a0","article-title":"The crystal structure of diphtheria toxin","volume":"357","author":"Choe","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.biologicals.2011.05.004_bib15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1432-1033.1997.00320.x","article-title":"Comparison of the diphtheria mutant toxin, CRM197, with a Haemophilus influenzae type-b polysaccharide-CRM197 conjugate by optical spectroscopy","volume":"246","author":"Crane","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.biologicals.2011.05.004_bib16","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0019-2791(72)90163-2","article-title":"An immunological study of the diphtheria toxin molecule","volume":"9","author":"Pappenheimer","year":"1972","journal-title":"Immunochemistry"},{"key":"10.1016\/j.biologicals.2011.05.004_bib17","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1128\/MCB.4.4.642","article-title":"In vitro biosynthesis of diphthamide, studied with mutant Chinese hamster ovary cells resistant to diphtheria toxin","volume":"4","author":"Moehring","year":"1984","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.biologicals.2011.05.004_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1128\/MMBR.39.1.54-85.1975","article-title":"Diphtheria toxin: mode of action and structure","volume":"39","author":"Collier","year":"1975","journal-title":"Bacteriol Rev"},{"key":"10.1016\/j.biologicals.2011.05.004_bib19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.vaccine.2003.08.003","article-title":"Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines","volume":"22","author":"Metz","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.05.004_bib20","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.1016\/j.vaccine.2007.07.009","article-title":"Quality control of routine, experimental and real-time aged diphtheria toxoids by in\u00a0vitro analytical techniques","volume":"25","author":"Metz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.05.004_bib21","series-title":"Structural characterisation of diphtheria toxoid","author":"Metz","year":"2005"},{"key":"10.1016\/j.biologicals.2011.05.004_bib22","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/S0264-410X(99)00535-6","article-title":"Quantitative determination of saccharide in Haemophilus influenzae type b glycoconjugate vaccines, alone and in combination with DPT, by use of high-performance anion-exchange chromatography with pulsed amperometric detection","volume":"18","author":"Bardotti","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.05.004_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.182.4110.353","article-title":"Diphtheria","volume":"182","author":"Pappenheimer","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.biologicals.2011.05.004_bib24","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1016\/S0021-9258(19)43810-6","article-title":"Diphtheria toxin and related proteins. I. Isolation and properties of mutant proteins serologically related to diphtheria toxin","volume":"248","author":"Uchida","year":"1973","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biologicals.2011.05.004_bib25","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/nar\/12.10.4063","article-title":"The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197","volume":"12","author":"Giannini","year":"1984","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biologicals.2011.05.004_bib26","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1128\/JB.153.3.1202-1210.1983","article-title":"Integration of corynebacteriophages beta tox+, omega tox+, and gamma tox- into two attachment sites on the Corynebacterium diphtheriae chromosome","author":"Rappuoli","year":"1983","journal-title":"J\u00a0Bacteriol.15"},{"key":"10.1016\/j.biologicals.2011.05.004_bib27","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.05.004_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/abio.1998.2682","article-title":"Quantitative restriction fragment length polymorphism: a procedure for quantitation of diphtheria toxin gene CRM197 allele","volume":"260","author":"Pushnova","year":"1998","journal-title":"Anal Biochem"},{"key":"10.1016\/j.biologicals.2011.05.004_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00191698","article-title":"Determination of diphtheria toxin neutralizing antibody titers with a cell protein systhesis inhibition assay","volume":"180","author":"Padovan","year":"1991","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.biologicals.2011.05.004_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-5793(87)81060-8","article-title":"Conformational changes in diphtheria toxoids. Analysis with monoclonal antibodies","volume":"218","author":"Bigio","year":"1987","journal-title":"FEBS Lett"},{"key":"10.1016\/j.biologicals.2011.05.004_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-5793(87)80116-3","article-title":"Diphtheria toxin and its mutant CRM197 differ in their interaction with lipids","volume":"215","author":"Papini","year":"1987","journal-title":"FEBS Lett"},{"key":"10.1016\/j.biologicals.2011.05.004_bib32","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1016\/j.vaccine.2010.04.072","article-title":"Overview of the development and current use of CRM(197) conjugate vaccines for pediatric use","volume":"28","author":"Shinefield","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.05.004_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0005-2736(87)90132-5","article-title":"Single mutation in the A domain of diphtheria toxin results in a protein with altered membrane insertion behavior","volume":"902","author":"Hu","year":"1987","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biologicals.2011.05.004_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jb\/mvm116","article-title":"Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activity","volume":"142","author":"Kageyama","year":"2007","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.biologicals.2011.05.004_bib35","doi-asserted-by":"crossref","first-page":"12148","DOI":"10.1016\/S0021-9258(17)38999-8","article-title":"Binding properties of diphtheria toxin to cells are altered by mutation in the fragment A domain","volume":"260","author":"Mekada","year":"1985","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biologicals.2011.05.004_bib36","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1073\/pnas.87.8.2995","article-title":"Diphtheria toxin and its ADP-ribosyltransferase-defective homologue CRM197 possess deoxyribonuclease activity","volume":"87","author":"Bruce","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biologicals.2011.05.004_bib37","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/infdis\/142.5.716","article-title":"Immunogenic correlation between cross-reacting material (CRM197) produced by a mutant of Corynebacterium diphtheriae and diphtheria toxoid","volume":"142","author":"Porro","year":"1980","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.biologicals.2011.05.004_bib38","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0264-410X(97)00034-0","article-title":"Differences in the immunogenicity of native and formalinized cross reacting material (CRM197) of diphtheria toxin in mice and guinea pigs and their implications on the development and control of diphtheria vaccine based on CRMs","volume":"15","author":"Gupta","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.05.004_bib39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.toxicon.2007.09.010","article-title":"Diphtheria toxin mutant CRM197 is an inhibitor of protein synthesis that induces cellular toxicity","volume":"51","author":"Qiao","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.05.004_bib40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jb\/mvm115","article-title":"Transgenic mice expressing a fully nontoxic diphtheria toxin mutant, not CRM197 mutant, acquire immune tolerance against diphtheria toxin","volume":"142","author":"Kimura","year":"2007","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.biologicals.2011.05.004_bib41","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.vaccine.2004.09.028","article-title":"Double-blind study comparing the immunogenicity of a licensed DTwPHib-CRM197 conjugate vaccine (Quattvaxem) with three investigational, liquid formulations using lower doses of Hib-CRM197 conjugate","volume":"23","author":"Tamm","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.05.004_bib42","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00262-004-0546-4","article-title":"CRM197 (nontoxic diphtheria toxin): effects on advanced cancer patients","volume":"53","author":"Buzzi","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.biologicals.2011.05.004_bib43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-59745-210-6_8","article-title":"2B-Trans technology: targeted drug delivery across the blood-brain barrier","volume":"437","author":"Gaillard","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.biologicals.2011.05.004_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4161\/hv.2.4.2942","article-title":"Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants","volume":"2","author":"Kanra","year":"2006","journal-title":"Hum Vaccines"},{"key":"10.1016\/j.biologicals.2011.05.004_bib45","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3855\/jidc.1048","article-title":"Conjugate vaccines for enteric fever: proceedings of a meeting organized in New Delhi, India in 2009","volume":"4","author":"Podda","year":"2010","journal-title":"J\u00a0Infect Dev Ctries"},{"key":"10.1016\/j.biologicals.2011.05.004_bib46","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1016\/j.vaccine.2010.01.012","article-title":"Beta-glucan-CRM conjugates as candidates antifungal vaccines","volume":"28","author":"Bromuro","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.05.004_bib47","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1016\/j.vaccine.2011.02.039","article-title":"Immunogenicity and physico-chemical characterisation of a candidate conjugate vaccine against group B streptococcus serotypes Ia, Ib and III","volume":"29","author":"Lancaster","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.05.004_bib48","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1586\/erv.10.86","article-title":"Current status of pneumococcal vaccines: lessons to be learned and new insights","volume":"9","author":"Dinleyici","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.biologicals.2011.05.004_bib49","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.vaccine.2009.01.005","article-title":"The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants","volume":"27","author":"P\u00f6llabauer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.05.004_bib50","first-page":"79","article-title":"A\u00a0phase-I clinical trial of a new antitetanus\/antidiphtheria vaccine for adults","volume":"3","author":"Podda","year":"1991","journal-title":"Ann Ig"},{"key":"10.1016\/j.biologicals.2011.05.004_bib51","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0264-410X(00)00309-1","article-title":"A\u00a0mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery","volume":"19","author":"McNeela","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.05.004_bib52","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1128\/IAI.71.2.726-732.2003","article-title":"Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin A","volume":"71","author":"Mills","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2011.05.004_bib53","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.vaccine.2003.09.012","article-title":"Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan","volume":"22","author":"McNeela","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.05.004_bib54","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1128\/IAI.73.12.8256-8265.2005","volume":"73","author":"Huo","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2011.05.004_bib55","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/IAI.00797-07","article-title":"Transcutaneous immunization with cross-reacting material CRM197 of diphtheria toxin boosts functional antibody levels in mice primed parenterally with adsorbed diphtheria toxoid vaccine","volume":"76","author":"Stickings","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2011.05.004_bib56","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0014-5793(98)00474-8","article-title":"van OJ. Unique chemical reactivity of His-21 of CRM-197, a mutated diphtheria toxin","volume":"427","author":"Chang","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.biologicals.2011.05.004_bib57","first-page":"3713","article-title":"New approach to cancer therapy: heparin binding-epidermal growth factor-like growth factor as a novel targeting molecule","volume":"27","author":"Miyamoto","year":"2007","journal-title":"Anticancer Res"},{"key":"10.1016\/j.biologicals.2011.05.004_bib58","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1002\/ijc.25472","article-title":"HB-EGF orchestrates the complex signals involved in triple-negative and trastuzumab-resistant breast cancer","volume":"127","author":"Yotsumoto","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.biologicals.2011.05.004_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1247\/csf.09025","article-title":"Humanized gene replacement in mice reveals the contribution of cancer stroma-derived HB-EGF to tumor growth","volume":"35","author":"Ichise","year":"2010","journal-title":"Cell Struct Funct"},{"key":"10.1016\/j.biologicals.2011.05.004_bib60","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1091\/mbc.6.8.967","article-title":"Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity","volume":"6","author":"Goishi","year":"1995","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.biologicals.2011.05.004_bib61","doi-asserted-by":"crossref","first-page":"6866","DOI":"10.1016\/S0021-9258(17)38000-6","article-title":"Demonstration of diphtheria toxin receptors on surface membranes from both toxin-sensitive and toxin-resistant species","volume":"253","author":"Chang","year":"1978","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biologicals.2011.05.004_bib62","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/ijc.24031","article-title":"Synergistic anti-tumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancer","volume":"124","author":"Yagi","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.biologicals.2011.05.004_bib63","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1159\/000264689","article-title":"Inhibition of adrenocortical carcinoma by diphtheria toxin mutant CRM197","volume":"55","author":"Martarelli","year":"2009","journal-title":"Chemotherapy"},{"key":"10.1016\/j.biologicals.2011.05.004_bib64","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/cgt.2009.48","article-title":"Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy","volume":"17","author":"Fogar","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.biologicals.2011.05.004_bib65","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1038\/sj.onc.1209999","article-title":"Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance","volume":"26","author":"Wang","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.biologicals.2011.05.004_bib66","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10571-010-9496-x","article-title":"Diphtheria toxin mutant CRM197-mediated transcytosis across blood-brain barrier in\u00a0vitro","volume":"30","author":"Wang","year":"2010","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.biologicals.2011.05.004_bib67","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12031-010-9471-5","article-title":"CRM197-induced blood-brain barrier permeability increase is medited by upregulation of caveolin-1 protein","volume":"43","author":"Wang","year":"2011","journal-title":"J\u00a0Mol Neurosci"},{"key":"10.1016\/j.biologicals.2011.05.004_bib68","first-page":"575","article-title":"Meningococcal disease: a review on available vaccines and vaccines in development","volume":"98","author":"Br\u00f6ker","year":"2007","journal-title":"Minerva Med"},{"key":"10.1016\/j.biologicals.2011.05.004_bib69","first-page":"692","article-title":"MenACWY-CRM, a novel quadrivalent glycoconjugate vaccine against Neisseria meningitidis for the prevention of meningococcal infection","volume":"11","author":"Pace","year":"2009","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.biologicals.2011.05.004_bib70","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1586\/erv.09.18","article-title":"Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy","volume":"8","author":"Pace","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.biologicals.2011.05.004_bib71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998\u20132007: implications for prevention of meningococcal disease","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biologicals.2011.05.004_bib72","series-title":"Prescribing information","author":"Menactra","year":"2011"},{"key":"10.1016\/j.biologicals.2011.05.004_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2011.03.043","article-title":"Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well\u00a0tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: an open, randomized controlled trial","author":"Vesikari","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.05.004_bib74","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/adc.2007.136036","article-title":"A\u00a0novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial","volume":"93","author":"Pace","year":"2008","journal-title":"Arch Dis Child"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105611000650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105611000650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T23:55:31Z","timestamp":1637970931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105611000650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1045105611000650"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2011.05.004","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}